Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: 堀部, 佳代, 森野, 勝太郎, 宮澤, 伊都子, 近藤, 慶子, 佐藤, 大介, 大橋, 夏子, 井田, 昌吾, 柳町, 剛司, 吉村, 雅寛, 井藤, 隆太, 村田, 喜代史, 三浦, 克之, 有馬, 久富, 藤田, 征弘, 卯木, 智, 前川, 聡, HORIBE, Kayo, Tanaka-Mizuno, Sachiko, SATO, Daisuke, OHASHI, Natsuko, IDA, Shogo, YANAGIMACHI, Tsuyoshi, YOSHIMURA, Masahiro, ITOH, Ryuta, MIURA, Katsuyuki, ARIMA, Hisatomi, FUJITA, Yukihiro, UGI, Satoshi, MAEGAWA, Hiroshi
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7145036622